Malaysia : Sinopharm + Janssen Vaccines Approved!

Spread the love

Malaysia has conditionally approved the Sinopharm and Janssen COVID-19 vaccines!

Find out this means for the COVID-19 vaccination program in Malaysia!


Malaysia Approves Sinopharm + Janssen COVID-19 Vaccines!

On 16 July 2021, the Malaysia Ministry of Health announced that the Drug Control Authority (DCA) issued a conditional registration for the following vaccines :

  1. COVILO Suspension for Injection COVID-19 Vaccine (Vero Cell), Inactivated
    Registrant : Duopharma (M) Sdn. Bhd.
    Manufacturer : Beijing Institute of Biological Products Co. Ltd. (BIBP), China
    COVILO is also known as Sinopharm COVID-19 vaccine, and was developed by China National Biotec Group Company Limited (CNBG), also known as Sinopharm
  2. Janssen COVID-19 Vaccine Suspension for Injection
    Registrant : Johnson & Johnson Sdn. Bhd.
    Manufacturer : Janssen Pharmaceutica N.V., Belgium

This conditional registration allows both COVID-19 vaccines to be used in the Malaysia COVID-19 vaccination program.

Malaysia : Sinopharm + Janssen Vaccines Approved!


Sinopharm + Janssen Vaccines : A Quick Primer!

The Sinopharm COVILO vaccine, also known as BBIBP-CorV or just BIBP, that is very similar to the CoronaVac vaccine made by Sinovac.

Like CoronaVac, COVILO is an inactivated virus vaccine made from actual SARS-CoV-2 virus grown in Vero cells, and killed using β-propiolactone.

Once injected into the body, the antigens on the inactivated SARS-CoV-2 virus triggers the body’s immune system. It is a two-shot vaccine with an efficacy of :

  • 79% against symptomatic COVID-19.
  • 79% against hospitalisation with COVID-19

Sinopharm COVID-19 vaccine

The Janssen vaccine from Johnson & Johnson is a viral-vector vaccine that uses the same Ad26 adenovirus as the Russian Sputnik V vaccine.

Once injected into the body, the Ad26 virus teaches some of our cells to manufacture the SARS-CoV-2 protein spikes to trigger the body’s immune system.

The Janssen vaccine is a single-shot vaccine with an efficacy of :

  • 52% to 74% against mild to moderate COVID-19.
  • 73% to 82% against severe to critical COVID-19

Janssen COVID-19 vaccine


Please Support My Work!

If you would like to support my work, you can do so via bank transfer /  PayPal / credit card.

Name : Adrian Wong

Bank Transfer : CIMB 7064555917 (Swift Code : CIBBMYKL)
Credit Card / Paypal :

Thank you in advanced! ❤️


Recommended Reading

Go Back To > HealthTech ARP


Support Tech ARP!

Please support us by visiting our sponsors, participating in the Tech ARP Forums, or donating to our fund. Thank you!

About The Author

Leave a Reply